Yale Cancer Center Study Shows Long-Term Survival Benefits for Lung Cancer Patients
As per the global study led by Yale Cancer Center, a tiny amount of biomarker known as PD-L1 can predict long-term survival benefits from pembrolizumab. Pembrolizumab (Keytruda) is one of the first inhibitors to be used in the treatment for lung cancer. These recent findings have been published online in the Journal of Clinical Oncology. The findings come [...]
Communicating With Children about Your Lung Cancer
Lung Cancer diagnosis has a drastic impact not only on the patient but also on the entire family. You have to make a lot of decisions regarding your treatment options. The one [...]
Lung Cancer Rates Are On the Rise among Young Women
An International Journal of Cancer study examined lung cancer rates in young adults in 40 countries across five continents. The study has found that a recent trend of higher [...]
Late Diagnosis of Lung Cancer Hits Survival Rates Among Patients
People with lung cancer are dying owing to the late diagnosis of the disease. One of the best ways to improve survival rates is the early detection. The most common symptoms [...]
Malfunctioning of Immune System May Increase Risk of Lung Cancer
The deadly disease of lung cancer is not only present among smokers but is also posing a threat to non-smokers as well. The most vital factor that works to save patients from [...]
Genomic Analyzes Predict Response to Immunotherapy in Lung Cancer Patients
Researchers from Johns Kimmel Cancer Center, Bloomberg-Kimmel Institute for Cancer Immunotherapy, and the Johns Hopkins University School of Medicine, have developed a [...]
Record-Setting Drop in US Cancer Death Rate in a Single Year
According to the latest report from the American Cancer Society, the cancer death rate in US has dropped 2.2% from 2016 to 2017. This is the largest single-year drop ever [...]
Obesity May Boost Effectiveness of Lung Cancer Treatment, According to Study
The latest study in the field of lung cancer has revealed that an immune system-based treatment for lung cancer, worked better in people who were overweight in some trials. In [...]
Relationship between Cough and Lung Cancer
When it comes to the health of the lungs, don’t takes chances if you are getting cough that is not quitting. You should learn everything about your cough or any other [...]
Oligometastatic Non-Small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) is one of the most deadly diseases and is affecting a large number of people all over the world. In the recent years, an increased interest [...]
Lung Cancer Screenings Could Detect Signs of Heart Disease via Artificial Intelligence
According to a study presented at the annual meeting of the Radiological Society of North America, artificial intelligence could measure a common marker of heart disease in [...]
Artificial Intelligence to Determine Who Will Benefit from Immunotherapy
Scientists can now determine which lung cancer patients will benefit from the expensive immunotherapy. They have previously used AI to determine the type of lung cancer. Now, [...]
Nintedanib for Treatment of Advanced Lung Cancer
November is recognized as Lung Cancer Awareness Month all over the world. New and advanced researches continue to work in the arena of lung cancer treatment. The University of [...]
Lung Cancer Report in US Offers a Mixed Bag of Good News and Bad News
The American Lung Association has recently published “State of Lung Cancer” report in November, Lung Cancer Awareness Month. The analysis of the report says that most [...]
Lung Cancer Awareness Month: Latest Researches in Lung Cancer Treatment
Lung Cancer Awareness Month is observed every year in the month of November. It intends to educate public about signs and symptoms of lung cancer. Creating awareness about [...]